Spermatech AS has entered a drug optimization and development program with SINTEF. Spermatech has also began a collaboration with Norsvin to perform our field trial studies using our new promising sperm activator.
Spermatech has filed a patent on their inhibitors for application as a male contraceptive.
Spermatech has achieved an R&D grant for their sperm activator project to increase the efficiency of artificial insemination used in animal breeding from the BIONÆR program run by the Norwegian Research Council. BIONÆR – Sustainable Innovation in Food and Bio-based Industries